Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001722024-19-000006
Filing Date
2019-05-08
Accepted
2019-05-08 20:32:01
Documents
1
Period of Report
2019-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_155736190564078.html 3  
1 FORM 3 wf-form3_155736190564078.xml 3 6228
  Complete submission text file 0001722024-19-000006.txt   7837
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101
Business Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 19808470